See up to 3 months of IMTX. The 7-day demo opens the 1M and 3M ranges and puts IMTX on your watchlist.
Start 7-day demoLatest IMTX insider trades
About Immatics N.V. (IMTX)
Immatics N.V. is an SEC registrant, filing under CIK 0001809196, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
IMTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 863,060 | $7.50M |
| Grant or award | 2 | 225,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IMTX insider transactions (Form 4)
1211 Form 4 filings on record, the earliest from Jun 18, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC - Director | Open-market purchase | Ordinary Shares | 863,060 | $8.69 | $7.50M | |
| James Nelson Pepin - Officer | Grant or award | Stock Option (Right to Buy) | 181,200 | $0.00 | - | |
| James Nelson Pepin - Officer | Grant or award | Restricted Stock Units | 43,800 | $0.00 | - | |
| Adam Leo Stone - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
| Alise Reicin - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
| Michael G. Atieh - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
| Paul Rutherford Carter - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
 Eliot Forster - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
| Peter Alan Chambre - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
| Heather L. Mason - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
| PERCEPTIVE ADVISORS LLC | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - | |
 Mathias Hothum - Director | Grant or award | Stock Option (Right to Buy) | 48,000 | $0.00 | - |
IMTX insider trading FAQ
What is the latest insider trade for IMTX?
Immatics N.V. (IMTX) had 2 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for IMTX runs to 11 Form 4 filings, the earliest from 2026-06-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMTX stock?
1 insider purchase of IMTX was filed in the last 90 days, totaling $7.50M.
How many insiders are selling IMTX stock?
No insider sales of IMTX were filed in the last 90 days.
Where can I see IMTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - PERCEPTIVE ADVISORS LLC view on EDGAR
- - James Nelson Pepin view on EDGAR
- - Adam Leo Stone view on EDGAR
- - Alise Reicin view on EDGAR
- - Michael G. Atieh view on EDGAR
- - Paul Rutherford Carter view on EDGAR
- - Eliot Forster view on EDGAR
- - Peter Alan Chambre view on EDGAR
- - Heather L. Mason view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where IMTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMTX with a 7-day demo
- IMTX on your watchlist
- Every IMTX Form 4 filing on record
- Up to 3 months of IMTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
